входит в структуру портала
Hoffmann-La Roche Ltd. (Roche) is a global health-care company operating in the fields of pharmaceuticals and diagnostics, the manufacturer of the medicines for oncology, virology, rheumatology and transplantology. The headquarters are in Switzerland.

  • Fuzeon (Enfuvirtide)
  • Invirase (Saquinavir)
  • Viracept (Nelfinavir)

HepC portfolio:

  • Pegasys (PEGylated interferon)
  • Roferon-A (Interferon alfa-2a)

Information about the drug products is obtained from public sources or from company representatives and is intended solely for informing community representatives about the options currently available or in development. This information can under no circumstances be intepreted as advertising. The mentioning of any drug products does not mean EECA CAB prioritizes those products or, on the contrary, does not recommend them.

Hepatitis C pipeline

  • Non-nucleoside polymerase inhibitors
    • mericitabine (RG7128), twice a day, phase III
  • Inhibitors of NS5A
    • setrobuvir (ANA-595), twice a day, phase II
  • Protease inhibitors
    • danoprevir/r (RG7227), twice a day, phase II

Search our site ...